Literature DB >> 20111991

Early effects of aluminum chloride on beta-secretase mRNA expression in a neuronal model of beta-amyloid toxicity.

Alessandro Castorina1, Adriana Tiralongo, Salvatore Giunta, Maria Luisa Carnazza, Giovanni Scapagnini, Velia D'Agata.   

Abstract

Amyloid beta peptide (Abeta), generated by proteolytic cleavage of the amyloid precursor protein (APP), plays a pivotal role in the pathogenesis of Alzheimer's disease (AD). The key step in the generation of Abeta is cleavage of APP by beta-secretases (beta-site APP-cleaving enzyme 1 (BACE1) and BACE2). There has been suggestion of interaction between aluminum and several AD-associated pathways. However, the underlying mechanisms still remain unclear. Here, we report the effects of aluminum chloride (AlCl(3)) in Abeta-induced toxicity using differentiated neuronal SH-SY5Y cells. The metal significantly enhances Abeta-induced cell death at concentrations ranging from 50 to 300 microM after 24 and 48 h. After 72 and 96 h treatment, cell death is increased already at 10 microM. Early coexposure of cells to 10 microM AlCl(3) and 2 microM Abeta differentially affected beta-secretase mRNA levels as compared to single Abeta treatment after 1 and 3 h. BACE1 levels were slightly reduced after 1 h and significantly increased after 3 h exposure, whereas BACE2 levels were increased at both times considered. Both genes' mRNA levels were downregulated at longer times (6, 12, and 24 h). Although these results indicate that aluminum toxicity is correlated to changes in both BACE1 and BACE2 expression levels, the subsequent common downregulation observed suggests that aluminum involvement in the Abeta cascade is subtle, and other underlying mechanisms might be involved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20111991     DOI: 10.1007/s10565-009-9149-3

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN: 0742-2091            Impact factor:   6.691


  14 in total

1.  Effects of aluminium on β-amyloid (1-42) and secretases (APP-cleaving enzymes) in rat brain.

Authors:  Linping Wang; Jiali Hu; Yue Zhao; Xiaoting Lu; Qinli Zhang; Qiao Niu
Journal:  Neurochem Res       Date:  2014-05-03       Impact factor: 3.996

Review 2.  Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts.

Authors:  Calvin C Willhite; Nataliya A Karyakina; Robert A Yokel; Nagarajkumar Yenugadhati; Thomas M Wisniewski; Ian M F Arnold; Franco Momoli; Daniel Krewski
Journal:  Crit Rev Toxicol       Date:  2014-10       Impact factor: 5.635

3.  Link between Aluminum and the Pathogenesis of Alzheimer's Disease: The Integration of the Aluminum and Amyloid Cascade Hypotheses.

Authors:  Masahiro Kawahara; Midori Kato-Negishi
Journal:  Int J Alzheimers Dis       Date:  2011-03-08

4.  Reduction of aluminum ion neurotoxicity through a small peptide application - NAP treatment of Alzheimer's disease.

Authors:  Ming-Hui Yang; Shih-Cheng Chen; Yu-Fen Lin; Yi-Chia Lee; Ming-Yii Huang; Ko-Chin Chen; Hsin-Yi Wu; Po-Chiao Lin; Illana Gozes; Yu-Chang Tyan
Journal:  J Food Drug Anal       Date:  2019-01-12       Impact factor: 6.157

5.  Hippocampal neuronal cyclooxygenase-2 downstream signaling imbalance in a rat model of chronic aluminium gluconate administration.

Authors:  Hong Wang; Mengliang Ye; Lijuan Yu; Jianfeng Wang; Yuanxin Guo; Wenjuan Lei; Junqing Yang
Journal:  Behav Brain Funct       Date:  2015-02-18       Impact factor: 3.759

6.  The seeming paradox of adenosine receptors as targets for the treatment of Alzheimer's disease: agonists or antagonists?

Authors:  Rubina Marzagalli; Alessandro Castorina
Journal:  Neural Regen Res       Date:  2015-02       Impact factor: 5.135

7.  Expression profile of Wilms Tumor 1 (WT1) isoforms in undifferentiated and all-trans retinoic acid differentiated neuroblastoma cells.

Authors:  Grazia Maugeri; Agata Grazia D'Amico; Daniela Maria Rasà; Rita Reitano; Salvatore Saccone; Concetta Federico; Rosalba Parenti; Gaetano Magro; Velia D'Agata
Journal:  Genes Cancer       Date:  2016-01

Review 8.  Environmental exposures and the etiopathogenesis of Alzheimer's disease: The potential role of BACE1 as a critical neurotoxic target.

Authors:  Tauqeerunnisa Syeda; Jason R Cannon
Journal:  J Biochem Mol Toxicol       Date:  2021-01-04       Impact factor: 3.642

9.  Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer's disease.

Authors:  Manal Fouad Ismail; Aliaa Nabil Elmeshad; Neveen Abdel-Hameed Salem
Journal:  Int J Nanomedicine       Date:  2013-01-23

10.  Hemodynamic and neuropathological analysis in rats with aluminum trichloride-induced Alzheimer's disease.

Authors:  Szu-Ming Chen; Chi-Chen Fan; Ming-Shiuan Chiue; Chi Chou; Jyh-Horng Chen; Ruey-Shyang Hseu
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.